Praxis Precision Medicines (PRAX) Return on Equity (2022 - 2025)
Historic Return on Equity for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to 0.78%.
- Praxis Precision Medicines' Return on Equity fell 3700.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.78% for FY2024, which is 9600.0% up from last year.
- Per Praxis Precision Medicines' latest filing, its Return on Equity stood at 0.78% for Q3 2025, which was down 3700.0% from 0.64% recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Return on Equity registered a high of 0.41% during Q2 2024, and its lowest value of 2.62% during Q1 2023.
- Its 4-year average for Return on Equity is 1.17%, with a median of 0.83% in 2024.
- As far as peak fluctuations go, Praxis Precision Medicines' Return on Equity soared by 17500bps in 2024, and later tumbled by -3700bps in 2025.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Return on Equity stood at 2.37% in 2022, then skyrocketed by 32bps to 1.62% in 2023, then soared by 70bps to 0.48% in 2024, then plummeted by -62bps to 0.78% in 2025.
- Its last three reported values are 0.78% in Q3 2025, 0.64% for Q2 2025, and 0.53% during Q1 2025.